Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin provocation in patients with systemic mastocytosis
2015-004604-37Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Jul 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aspirin in systemic mastocytosis (SM), sponsored by Erasmus MC. Primary endpoint: Frequency and severity of anaphylaxis/hypersensitivity reactions. Started Jul 2016; status: active.
02
Drugs
aspirin
03
Conditions
systemic mastocytosis (SM)
Beyond the preview
Go deeper on 2015-004604-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004604-37.